糖蛋白组学
糖蛋白
生物标志物
化学
乳腺癌
生物标志物发现
细胞外小泡
计算生物学
癌症
蛋白质组学
聚糖
生物化学
细胞生物学
生物
医学
内科学
基因
作者
I-Hsuan Chen,Hillary Andaluz Aguilar,Sebastian Juan Paez,Xiaofeng Wu,Pan Li,Michael K. Wendt,Anton B. Iliuk,Ying Zhang,W. Andy Tao
标识
DOI:10.1021/acs.analchem.8b01090
摘要
Glycoproteins comprise more than half of current FDA-approved protein cancer markers, but the development of new glycoproteins as disease biomarkers has been stagnant. Here we present a pipeline to develop glycoproteins from extracellular vesicles (EVs) through integrating quantitative glycoproteomics with a novel reverse phase glycoprotein array and then apply it to identify novel biomarkers for breast cancer. EV glycoproteomics show promise in circumventing the problems plaguing current serum/plasma glycoproteomics and allowed us to identify hundreds of glycoproteins that have not been identified in blood. We identified 1,453 unique glycopeptides representing 556 glycoproteins in EVs, among which 20 were verified significantly higher in individual breast cancer patients. We further applied a novel glyco-specific reverse phase protein array to quantify a subset of the candidates. Together, this study demonstrates the great potential of this integrated pipeline for biomarker discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI